PMID: 6987992Mar 1, 1980Paper

Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus

Arthritis and Rheumatism
C K AbrassR J Glassock

Abstract

Serial serum samples from 48 patients with systemic lupus erythematosus (SLE) were assayed for C3, anti-DNA antibody, and circulating immune complexes (CIC). CIC were measured by the fluid phase (FClq) and solid phase (SClq) Clq binding assays. Elevations of the SClq results were associated with the presence of manifestations of SLE (P less than 0.001), including active renal disease (P less than 0.005) and arthritis (P less than 0.001), as well as changes in degree of disease activity which prompted physician action. A change in the SClq results correctly predicted a change in disease activity 82% of the time (P less than 0.005). Abnormalities of FClq, anti-DNA antibody, and C3 were neither associated with nor predictive of changes in disease activity of SLE. These data suggest that the SClq method of determining CIC is the most reliable laboratory indicator of clinical activity in SLE.

References

Mar 12, 1977·Lancet·R J LevinskyJ F Soothill
Jan 1, 1977·Arthritis and Rheumatism·S A LeonB Shapiro
Sep 1, 1976·Arthritis and Rheumatism·R W Lightfoot, G R Hughes
Sep 1, 1976·The Journal of Investigative Dermatology·E M Tan
Jan 1, 1975·Scandinavian Journal of Rheumatology. Supplement·R W LightfootN Levesanos
Feb 1, 1973·Kidney International·V AgnelloH G Kunkel
Jan 1, 1966·International Archives of Allergy and Applied Immunology·P J McConahey, F J Dixon
Feb 1, 1972·The Journal of Clinical Investigation·P G Natali, E M Tan
May 1, 1972·The Journal of Clinical Investigation·S M MauerA F Michael
Apr 1, 1973·The Journal of Clinical Investigation·R J HarbeckR I Carr

❮ Previous
Next ❯

Citations

Oct 17, 2002·Arthritis and Rheumatism·Arthur F KavanaughUNKNOWN American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines
Jan 1, 1995·Rheumatology International·P K TrinderM Loos
Jan 1, 1986·Rheumatology International·M Gripenberg, T Helve
Jun 17, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Neta MosesCraig Nicholas
Feb 1, 1981·Medizinische Monatsschrift für Pharmazeuten·G Cohnen
Mar 5, 1998·Clinical and Experimental Immunology·R H van den BergM R Daha
Dec 1, 1981·The Journal of Experimental Medicine·G BieseckerD Koffler
Oct 23, 2012·International Journal of Rheumatic Diseases·Ronald HerbstYihong Yao
Feb 1, 1982·Annals of the Rheumatic Diseases·H Al-HadithyM L Snaith
Aug 6, 1983·British Medical Journal·M L Snaith
Jul 27, 2000·Journal of Clinical Pathology·W Egner
Mar 1, 1985·The Journal of Clinical Investigation·E H ColeG A Levy
Sep 10, 2004·Current Rheumatology Reports·Chau-Ching LiuJoseph M Ahearn
Mar 16, 2004·Current Rheumatology Reports·Chau-Ching LiuSusan Manzi
Sep 20, 1991·Journal of Immunological Methods·H P SeeligM Renz
Oct 9, 2009·Autoimmunity·Emese KissPeter Szodoray
May 1, 1982·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W M BennettD C Houghton
Sep 1, 1985·Kidney International·W G Couser
May 1, 1991·Kidney International·L A HebertJ C Neff
Mar 1, 1982·Kidney International·S A CairnsN P Mallick
May 9, 2012·Pediatric Clinics of North America·Jay Mehta
Oct 20, 1998·Immunobiology·M J WalportM Botto
Mar 6, 2010·Rheumatic Diseases Clinics of North America·Chau-Ching LiuJoseph M Ahearn
Feb 27, 2010·Arthritis and Rheumatism·Amy H KaoSusan Manzi
Feb 1, 1982·The Journal of Dermatology·S MiyagawaK Sakamoto
Oct 27, 2017·Arthritis Research & Therapy·Noémie GensousUNKNOWN FHU ACRONIM
Jul 13, 2004·Arthritis and Rheumatism·Gabor G IlleiPeter E Lipsky
Dec 21, 2017·Lupus Science & Medicine·Ignacio Javier GandinoEnrique Roberto Soriano
Nov 1, 1985·Scandinavian Journal of Immunology·P FaaberJ H Berden
Jun 1, 1981·International Journal of Dermatology·N Brody
Oct 4, 2005·Arthritis and Rheumatism·Chau-Ching LiuJoseph M Ahearn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.